[Diagnosis and therapy of pneumocystis carinii pneumonia in a patient with AIDS].
The clinical, immunological and histological findings in a patient suffering the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia are discussed. At the time of diagnosis HTLV III antibodies were not demonstrable. Treatment with trimethoprim sulfamethoxazole achieved a remission lasting 7 months so far. HTLV III antibodies became demonstrable after 5 months; the markedly decreased Helper/Suppressor ratio of 0.30 remained unchanged.
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D017977:Deltaretrovirus / Q000276:immunology; D004338:Drug Combinations / Q000627:therapeutic use; D006716:Homosexuality; D006801:Humans; D007124:Immunoenzyme Techniques; D007370:Interferon Type I / Q000627:therapeutic use; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D012192:Retroviridae Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D013420:Sulfamethoxazole / Q000627:therapeutic use; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D007370:Interferon Type I; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole
Diagnostik und Therapie einer Pneumocystis-carinii-Pneumonie bei einem Patienten mit AIDS.